Tesamorelin 10mg Peptides
Equip your study with a peptide prepared for dependable, repeatable performance.
Primavora Tesamorelin is a lyophilized peptide supplied in a sealed research vial, unflavored and ready for controlled laboratory handling. This vial contains a total strength of 10mg, offering a clean, consistent starting material for methodical experimentation. As a growth hormone–releasing hormone analog, Tesamorelin is selected by researchers investigating endocrine signaling and related pathways where precision and reproducibility matter.
- Each vial contains 10mg of Tesamorelin, a synthetic growth hormone–releasing hormone analog examined for its role in pituitary signaling and the GH/IGF-1 axis under controlled laboratory conditions.
The lyophilized format supports stability throughout storage and shipment, allowing qualified personnel to reconstitute under laboratory protocols and proceed with accurate aliquoting as study designs require. Researchers value the straightforward handling profile: clear labeling, reliable identification, and a consistent material that integrates smoothly into established workflows. Whether you are setting up exploratory assays or tightening validation parameters, this presentation is engineered to reduce variables introduced by the starting compound.
Primavora emphasizes disciplined quality at every step. Each lot is produced under controlled conditions, lot-tracked, and independently tested for identity and purity to help ensure the material you receive aligns with the specifications your protocol demands. Documentation is maintained for transparency, enabling laboratories to review the details that support compliance and internal QA requirements.
As a USA-based research supplier, Primavora is committed to careful sourcing, rigorous standards, and clear labeling so scientists can focus on data integrity rather than material uncertainty. From receipt to study execution, our goal is to provide a dependable peptide aligned to modern laboratory expectations for consistency and control.
Ingredients: Tesamorelin.
For laboratory research use only. Not for human consumption. Not for veterinary use. Handle using appropriate laboratory safety procedures.
- Most orders ship within 24 hours and arrive within 3 to 5 days of leaving our warehouse.
- Shipping is free on orders of $99+ (except Hawaii and Alaska).
- All orders ship in discreet packaging via USPS Ground Advantage mail.
Delivery restrictions vary by state.
This Product Contains
Customer Reviews
There are no reviews yet. Be the first to write a review!
Frequently Asked Questions
What is Tesamorelin?
Tesamorelin is a synthetic analog of growth hormone-releasing hormone. It belongs to the same broad family as other GHRH-based peptides, but it is typically discussed as a distinct compound with its own pharmacologic profile. For a research-products site, it should be described as a laboratory peptide for GH-axis and metabolic-endocrine studies.
What is Tesamorelin typically studied for?
Tesamorelin is commonly studied for endogenous growth-hormone release, IGF-1 signaling, and body-composition or visceral-fat-related endocrine models. The best FAQ wording stays close to those research themes and avoids translating them into simplistic consumer promises.
What are GH peptides?
GH peptides — short for growth-hormone-related peptides — are a research category that includes two main subgroups. The first is growth-hormone-releasing hormone (GHRH) analogs, such as Sermorelin, Tesamorelin, and CJC-1295, which are studied for their interaction with the GHRH receptor. The second is growth hormone secretagogues, such as Ipamorelin, GHRP-2, GHRP-6, and Hexarelin, which are studied for their interaction with the ghrelin receptor (GHS-R1a).
Both subgroups are investigated in the research context of growth-hormone-axis biology. All GH peptide products from Prima Vora are lyophilized research compounds intended solely for in vitro laboratory investigation.
How do GH peptides differ from recombinant growth hormone?
Recombinant human growth hormone is the full 191-amino-acid human GH protein, produced via recombinant DNA technology. It is essentially identical to the endogenous hormone itself. GH peptides, by contrast, are much shorter sequences — typically on the order of a few to a few dozen amino acids — that do not act as GH themselves but rather engage upstream receptors (GHRH-R or GHS-R1a) involved in the GH signaling axis.
This makes the two categories mechanistically distinct. Recombinant GH is a replacement of the hormone itself, while GH peptides are research tools for studying the regulatory machinery that controls endogenous GH release.
What is the difference between GHRH analogs and GH secretagogues?
GHRH analogs are peptides modeled on the natural growth-hormone-releasing hormone sequence. They are studied for their ability to bind the GHRH receptor on the pituitary — the same receptor used by endogenous GHRH. Examples include Sermorelin (a GHRH 1-29 analog), Tesamorelin, and CJC-1295.
GH secretagogues are a structurally different class of peptides that act through the growth hormone secretagogue receptor (GHS-R1a), better known as the ghrelin receptor. Examples include Ipamorelin, GHRP-2, GHRP-6, and Hexarelin. The two classes engage different receptors and are therefore studied as distinct pharmacological families in research on GH signaling.
